ENDRA files S-4 for merger with ASP Isotopes subsidiary Noble Africa

ENDRA Life Sciences filed a Form S-4 registration statement to merge with Noble Africa, a subsidiary of ASP Isotopes. The deal aims to combine ASP's South African assets with a Nasdaq-listed entity pending regulatory approval.